OGN
Price
$9.36
Change
+$0.18 (+1.96%)
Updated
Aug 29, 12:27 PM (EDT)
Capitalization
2.39B
62 days until earnings call
VRBCF
Price
$346.00
Change
+$22.00 (+6.79%)
Updated
May 22 closing price
Capitalization
3.3B
Interact to see
Advertisement

OGN vs VRBCF

Header iconOGN vs VRBCF Comparison
Open Charts OGN vs VRBCFBanner chart's image
Organon & Co
Price$9.36
Change+$0.18 (+1.96%)
Volume$1.88K
Capitalization2.39B
Virbac SA
Price$346.00
Change+$22.00 (+6.79%)
Volume$23
Capitalization3.3B
OGN vs VRBCF Comparison Chart in %
Loading...
OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRBCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OGN vs. VRBCF commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OGN is a Buy and VRBCF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (OGN: $9.18 vs. VRBCF: $346.00)
Brand notoriety: OGN and VRBCF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: OGN: 85% vs. VRBCF: 100%
Market capitalization -- OGN: $2.39B vs. VRBCF: $3.3B
OGN [@Pharmaceuticals: Major] is valued at $2.39B. VRBCF’s [@Pharmaceuticals: Major] market capitalization is $3.3B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $656.17B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $88.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OGN’s FA Score shows that 1 FA rating(s) are green whileVRBCF’s FA Score has 0 green FA rating(s).

  • OGN’s FA Score: 1 green, 4 red.
  • VRBCF’s FA Score: 0 green, 5 red.
According to our system of comparison, VRBCF is a better buy in the long-term than OGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OGN’s TA Score shows that 5 TA indicator(s) are bullish while VRBCF’s TA Score has 1 bullish TA indicator(s).

  • OGN’s TA Score: 5 bullish, 5 bearish.
  • VRBCF’s TA Score: 1 bullish, 0 bearish.
According to our system of comparison, VRBCF is a better buy in the short-term than OGN.

Price Growth

OGN (@Pharmaceuticals: Major) experienced а -1.08% price change this week, while VRBCF (@Pharmaceuticals: Major) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.98%. For the same industry, the average monthly price growth was +1.16%, and the average quarterly price growth was +11.77%.

Reported Earning Dates

OGN is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.98% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRBCF($3.3B) has a higher market cap than OGN($2.39B). VRBCF has higher P/E ratio than OGN: VRBCF (17.05) vs OGN (3.42). VRBCF YTD gains are higher at: 1.996 vs. OGN (-37.061).
OGNVRBCFOGN / VRBCF
Capitalization2.39B3.3B72%
EBITDA1.5BN/A-
Gain YTD-37.0611.996-1,857%
P/E Ratio3.4217.0520%
Revenue6.28BN/A-
Total Cash599MN/A-
Total Debt8.9BN/A-
FUNDAMENTALS RATINGS
VRBCF: Fundamental Ratings
VRBCF
OUTLOOK RATING
1..100
46
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
PROFIT vs RISK RATING
1..100
50
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
OGNVRBCF
RSI
ODDS (%)
Bullish Trend 2 days ago
72%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
68%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
60%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
70%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
15%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
14%
Advances
ODDS (%)
Bullish Trend 3 days ago
67%
N/A
Declines
ODDS (%)
Bearish Trend 11 days ago
73%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
65%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
71%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRBCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JMUEX27.45N/A
N/A
JPMorgan US Equity L
OGGFX21.32N/A
N/A
JPMorgan Small Cap Growth I
PGRCX55.70N/A
N/A
BNY Mellon Worldwide Growth C
VDSCX20.58N/A
N/A
Victory Diversified Stock C
TSPFX6.05N/A
N/A
Transamerica Small Cap Growth R4

VRBCF and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRBCF has been loosely correlated with RCDTF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if VRBCF jumps, then RCDTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRBCF
1D Price
Change %
VRBCF100%
N/A
RCDTF - VRBCF
56%
Loosely correlated
N/A
OGN - VRBCF
1%
Poorly correlated
-0.22%
MIRA - VRBCF
1%
Poorly correlated
+2.19%
CSWYF - VRBCF
0%
Poorly correlated
N/A
JCRRF - VRBCF
-0%
Poorly correlated
N/A
More